Open Medicine
(Mar 2018)
Evaluation of a neurokinin-1 antagonist in preventing multiple-day cisplatin-induced nausea and vomiting
Li Quanfu,
Wang Wenjuan,
Chen Gang,
Deng Shuqin,
Jiang Caihong,
Chen Feng,
Zhao Jun,
Li Hui,
Bai Xiaojun,
Hu Yuliang,
Da Lenggaowa,
Wu Yungaowa,
Jin Gaowa
Affiliations
Li Quanfu
Department of Medical Oncology, Ordos Central Hospital, 017000Ordos, Mongolia, China
Wang Wenjuan
Department of Medical Oncology, Ordos Central Hospital, 017000Ordos, Mongolia, China
Chen Gang
Department of Medical Oncology, Ordos Central Hospital, 017000Ordos, Mongolia, China
Deng Shuqin
Department of Medical Oncology, Ordos Central Hospital, 017000Ordos, Mongolia, China
Jiang Caihong
Department of Medical Oncology, Ordos Central Hospital, 017000Ordos, Mongolia, China
Chen Feng
Department of Medical Oncology, Ordos Central Hospital, 017000Ordos, Mongolia, China
Zhao Jun
Department of Medical Oncology, Ordos Central Hospital, 017000Ordos, Mongolia, China
Li Hui
Department of Medical Oncology, Ordos Central Hospital, 017000Ordos, Mongolia, China
Bai Xiaojun
Department of Medical Oncology, Ordos Central Hospital, 017000Ordos, Mongolia, China
Hu Yuliang
Department of Medical Oncology, Ordos Central Hospital, 017000Ordos, Mongolia, China
Da Lenggaowa
Department of Medical Oncology, Ordos Central Hospital, 017000Ordos, Mongolia, China
Wu Yungaowa
Department of Medical Oncology, Ordos Central Hospital, 017000Ordos, Mongolia, China
Jin Gaowa
Ordos Central Hospital, Department of Medical Oncology, 23th Yinjihuoluo Western Road, Ordos, 017000, China
DOI
https://doi.org/10.1515/med-2018-0005
Journal volume & issue
Vol. 13,
no. 1
Abstract
Read online
To perform a prospective non-randomized comparison of the effectiveness and safety of combined neurokinin-1 antagonist aprepitant treatment with the standard multiple-day cisplatin regimen for the prevention of cisplatin-induced nausea and vomiting (CINV).
Keywords
WeChat QR code
Close
